Rubfila Board approves sale of Premier Tissues subsidiary for Rs 61 crore

Strategic Transactions View source PDF Explain this filing

RUBFILA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.4%Reaction day

₹68.05

prior close

₹69.90

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.3%+1.2% vs market

Rubber peers, median of 10sector-0.2%+1.6% vs sector

On the reaction day the stock moved 1.2 pts more than Nifty Microcap 250 and 1.6 pts more than its Rubber peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.6

10m

+0.1

15m

+0.1

30m

+0.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.4+0.3+1.2-0.2+1.6

Next day

-3.5+0.5-4.0-1.4-2.1

-4.5+0.1-4.6-2.1-2.4

-3.0+0.7-3.6-1.8-1.2

-1.7+0.4-2.1-1.7-0.0

-0.5+0.7-1.2+0.7-1.2

+1.5+0.1+1.5-1.8+3.3

15d

+1.4+1.5-0.1-3.7+5.1

-0.1+0.3-0.4-1.1+1.0

-16.1-6.2-10.0-11.4-4.7

—————

UpDownMarket · Nifty Microcap 250Sector · Rubber peers, median of 10Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Rubfila International's board approved selling its entire 100% stake in wholly-owned subsidiary Premier Tissues India Ltd (PTIL) to Finquest Personal Care Pvt Ltd for Rs 61 crore cash. PTIL contributed 15.68% of consolidated revenue (around Rs 95.74 crore) and 16.59% of net worth in FY26. The buyer is linked to promoter Hardik Patel, making it a related-party transaction. Proceeds will be paid within 30 days of approvals, and rerouted to the core rubber-thread business.

Likely market impact

Cash of Rs 61 crore to fund core rubber-thread business. PTIL ceases to be a subsidiary. Related-party deal needs shareholder approval.